Swedish researchers have set out to explore whether TNF inhibitor treatment for people with rheumatoid arthritis (RA) is associated with increased risk for cancer recurrence.Among 467 patients who were treated 42 had cancer recurrence (9.0%); whereas among 2164...
The US Food and Drug Administration has approved a new product for the management of opioid dependence. The novel products contains buprenorphine and naloxone in a biofilm formulation – for more information, refer here
An important study published more than 15 years ago, and which has stood the test of time. The South Australian researchers found that an age-adjusted dosing protocol rapidly achieved a stable INR with minimal overanticoagulation. Those with low serum albumin levels...
Sobering research recently published in the BMJ suggests that diclofenac is not as safe as other first generation NSAIDs from a cardiovascular point of view. The study examined 1 370 832 diclofenac initiators, 3 878 454 ibuprofen initiators, 291 490 naproxen...
Researchers from Spain have recently demonstrated what many clinicians have long suspected. In a study of nearly 47,000 people without clinically recognised atherosclerotic CVD, the subjects were stratified by presence of type 2 diabetes mellitus and as statin...
